. Anti-Tau Antibody Semorinemab Fails to Slow Alzheimer Disease. JAMA. 2022 Aug 2;328(5):415. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.